Makes Mounjaro and Zepbound (tirzepatide), currently the most effective GLP-1 drugs available. Has a manufacturing head start and a pipeline of next-generation weight loss treatments that could be taken as pills.
Invented the GLP-1 drug class. Makes Ozempic and Wegovy (semaglutide), the drugs that started the conversation. The original and dominant player, though facing stiff competition from Lilly.
Linked to Diabetes Management. Relies on Thermo Fisher. Competes with Medtronic and Boston Scientific.
Linked to Diabetes Management and Continuous Glucose Monitoring. Relies on Texas Instruments and Qualcomm. Competes with Abbott and Medtronic.
Linked to Diabetes Management. Competes with Dexcom and Abbott.
Want to explore how these companies connect to each other?